of unknown cause, is characterised by oral and genital ulcerations associated with systemic manifestations due to large and small vessel vasculitis. Ocular, cutaneous, and central nervous system involvement are often the translation of small vessel vasculitis.2 Crescentic glomerulonephritis has also been reported.3
Polymorphonuclear leucocytes have been incriminated in the physiopathology of Behcet's disease. Lesions are characterised histologically by acute inflammation and an intense infiltration of polymorphonuclear leucocytes with small vessel necrosis, especially at mucosal and cutaneous sites.4 The increased chemotaxis and random motility of polymorphonuclear leucocytes in Behcet's disease have been confirmed in several studies, and it has been suggested that a cytoplasmic polymorphonuclear leucocyte factor, serum or lymphocytic factor is responsible for this increased activity.5 To appreciate better the role of polymorphonuclear leucocytes in this disease we looked for the presence of antineutrophil cytoplasmic antibodies in patients with active and inactive Behcet's disease.
Twenty eight patients (27 male, one female) with a mean (SD) age of 40 (3) years (range 29-56) were studied. Disease durati .n was 6-8 (1-9) years (range 2-25). All patients had buccal aphthosis associated with at least two of the following criteria: genital aphthosis, cutaneous lesions, uveitis, and positive pathergy testing. The incidence of clinical manifestations with reported vasculitis is as follows: uveitis (12 cases), central nervous system disease (six cases), thrombophlebitis (six cases), erythema nodosum-like lesions (five cases), and arterial aneurysm (one case). The disease was active in 15 patients and inactive in 13. Indirect immunofluorescence on human neutrophils was used to detect antineutrophil cytoplasmic antibodies, according to the method of Van der Woude.6 None of the 28 serum samples from the patients with Behcet's disease was positive for these antibodies (titres >1/10). The fluorescence was negative in 27 patients and positive in one at a titre of 1/10.
This study strongly suggests that antineutrophil cytoplasmic antibodies cannot be incriminated as contributing to the abnormalities of polymorphonuclear leucocytes in Behqet's disease. an observation not included in our paper. Age of onset of first symptoms of RA and age at menopause (for this purpose defined as cessation of menses) were obtained from all women at the time of interview, in different sections of a questionnaire, with confirmation by recourse to hospital notes when possible. Seventeen women who had undergone hysterectomy and 17 women who were premenopausal were excluded from this analysis. There seemed to be a broad peak of age of onset of arthritis coinciding with the expected age of menopause (fig 1) . When the onset of arthritis was analysed in relation to the menopause in individual patients there were a larger number reporting onset of arthritis and menopause within an encompassing five year interval (fig 2) Sir: Dr McHugh makes some interesting points which we would like to consider in turn. It is correctly pointed out that the results of our two studies are at odds with each other with regard to perinatal death and risk of RA. The se'cond study was much larger and had greater power than the first, and was set up to explore the preliminary findings of the initial first study based on RA multicase families. As stated in the paper the results of the family study were based on small numbers of cases and perinatal episodes, and results could not be generalised to the wider sporadic RA population. Although these findings might
